Cargando…
Blocking GluR2–GAPDH ameliorates experimental autoimmune encephalomyelitis
OBJECTIVE: Multiple sclerosis (MS) is the most common disabling neurological disease of young adults. The pathophysiological mechanism of MS remains largely unknown and no cure is available. Current clinical treatments for MS modulate the immune system, with the rationale that autoimmunity is at the...
Autores principales: | Zhai, Dongxu, Lee, Frankie H F, D'Souza, Cheryl, Su, Ping, Zhang, Shouping, Jia, Zhengping, Zhang, Li, Wong, Albert H C, Liu, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402084/ https://www.ncbi.nlm.nih.gov/pubmed/25909084 http://dx.doi.org/10.1002/acn3.182 |
Ejemplares similares
-
Direct interaction between GluR2 and GAPDH regulates AMPAR-mediated excitotoxicity
por: Wang, Min, et al.
Publicado: (2012) -
PM486. Disrupting GluR2-GAPDH Interaction Affects Axon and Dendrite Development
por: Jhon, Min, et al.
Publicado: (2016) -
Therapeutic potential of blocking GAPDH nitrosylation with CGP3466b in experimental autoimmune encephalomyelitis
por: Godfrey, Wesley H., et al.
Publicado: (2023) -
GluR2(Q) and GluR2(R) AMPA Subunits are not Targets of lypd2 Interaction
por: Lauriello, Anna, et al.
Publicado: (2022) -
Expression of the AMPA Receptor Subunits GluR1 and GluR2 is Associated with Granule Cell Maturation in the Dentate Gyrus
por: Hagihara, Hideo, et al.
Publicado: (2011)